Dahunos, Baby Boy D.
HRN: 21-63-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2023
CEFUROXIME 750MG (VIAL)
10/24/2023
10/31/2023
IV
300mg
Q8
AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes